MANAGING DIRECTOR AND CEO, METEORIC BIOPHARMACEUTICALS
"We are looking into new ways to reap the benefits of artificial intelligence, particularly on the clinical side. On the physical side, Meteoric Biopharmaceuticals will have a new factory and lab up and running by the end of 2024, that will work on advanced fermentation processes."
"The biotech industry in India is currently extremely nascent, but it is evolving fast as generic margins drop, and many companies are starting to explore more innovative approaches to doing business. I anticipate Sai will take on more companies in the biotech sector in the future."
"With our expanding global footprint, we firmly believe that we are well positioned to achieve the vision of creating benchmarks and shaping the future of the clinical research industry by ensuring quality, reliability, and value-added services.”
"Personalized medicine will disrupt the pharma industry. I also see more people looking to leverage the digitization of patient care, such as through telemedicine or the creation of wearable technologies."
COMMISSIONER, FDCA (FOOD AND DRUG CONTROL ADMINISTRATION) GUJARAT
"In addition to pharmacy graduates, the pharmaceutical industry requires support from other industries like chemicals and petrochemicals, as well as top quality pharmacy machinery manufacturers. In Gujarat, we have all of this."
"We are working closely with our US partners to bring one of the most affordable point of care testing (POCT) devices to the market that will be saliva-based to provide the accuracy of a PCR machine on a POC device."
Ontario Mining and Toronto's Global Reach 2024 Pre-Release
This pre-release edition of Ontario Mining and Toronto's Global Reach 2024 comprises analysis based on over 40 interviews with the leading executives from major producers, associations, juniors, consultants, investors, and service providers, to provide an in-depth and holistic view of what is happening now, and more pertinently, what could happen in the years ahead.